Particle.news

Download on the App Store

Emperor Emeritus Akihito Hospitalized to Adjust New Heart Medication

He is receiving electrocardiogram-guided dose adjustments at University of Tokyo Hospital following limited improvement on prior therapy

Image
Image

Overview

  • He was diagnosed in May with asymptomatic myocardial ischemia and began medication to improve coronary blood flow.
  • After two months of little improvement, doctors recommended an additional oral therapy to reduce cardiac strain.
  • He was admitted to University of Tokyo Hospital on July 14 to initiate the new treatment under medical supervision.
  • The Imperial Household Agency has provided regular updates, noting that his length of stay will depend on his response to the treatment.
  • His cardiac history includes a 2012 coronary bypass surgery and a 2022 diagnosis of right heart failure from tricuspid valve insufficiency.